Wk 6: GI Flashcards
(47 cards)
1) What is the most prevalent chronic bacterial infection?
2) Who is infected?
3) What is it a common cause of?
1) H. pylori
2) Many people (~50% globally) infected, usually asymptomatic
3) Dyspepsia, gastritis, peptic ulcers, and increased gastric cancer risk
H. pylori diagnostic tests: What are the 2 categories? What are some tests included in each?
1) Non-invasive:
Stool antigen test
Urea Breath test
Serology (blood) test: not preferred
2) Invasive (endoscopic):
Biopsy urease test
Histology
Culture
1) Choice of test to diagnose H. pylori depends on what?
2) What should you do if it doesn’t need the more invasive form of testing?
1) Whether patient requires upper endoscopy to evaluate symptoms or for surveillance (such as to exclude malignancy); Endoscopy is not indicated solely to diagnose H. pylori
If gastric cancer needs to be excluded = endoscopy
2) Generally, if gastric cancer does not need to be excluded (i.e., endoscopy not indicated), then start with non-invasive testing to identify active H. pylori infection (stool antigen or urea breath test)
H. pylori tests:
1) How does Recent Proton Pump Inhibitor (PPI)/bismuth/antibiotic use (reduces bacterial load) affect them?
2) How long should a pt stop using PPIs?
3) What else can affect H. pylori tests?
1) Reduces test sensitivity for all endoscopic-based and non-invasive tests for active H. pylori infection
2) 1-2 weeks after stopping PPIs and at least 4 weeks after last bismuth/antibiotic use
3) Active peptic ulcer bleeding
Can limit sensitivity of endoscopic-based tests
Urea breath test (UBT) (non-invasive H. pylori test):
1) What is it commonly considered?
2) How does it work?
3) Describe the process/ interpretation
1) “Gold standard”: high sensitivity and specificity
2) H. pylori produces urease, which breaks down urea to produce CO2 and ammonia
3) Patient is given a drink of urea labeled with carbon 13 isotope (nonradioactive)
-If H. pylori is present,urease will break down urea which leads to C13-labeled CO2
Labeled CO2 is absorbed by capillaries and detectable in breath samples
Stool antigen test/assay (for H. pylori):
1) How does it work?
2) What are 2 pros to this method?
3) What version is not often used?
1) Uses monoclonal antibodies specific for H. pylori antigens
H. pyloriorganism does notsurvive in stool, but H. pylori antigen can be detected in fresh stool
2) More convenient and less expensive than urea breath test (but some pts don’t like using stool sample)
-Lab based monoclonal enzyme immunoassay has high sensitivity and specificity (comparable to UBT)
3) Rapid in-office monoclonal immunochromatographic test not highly utilized (low sensitivity)
Both the ____________ and __________ have good sensitivity/specificity either are recommended as the initial diagnostic tool for active H. pylori infection in patients who do not require endoscopy
urea breath test and stool antigen test
1) How does a Serology (Blood) test work for H. pylori?
2) Can it distinguish between all forms of infection?
1) Detects anti-H. pylori antibodies (IgG) using ELISA test
2) Cannot distinguish between active and past infection
Serology (Blood) test for H. Pylori
1) Is it expensive? Are the sensitivity and specificity good?
2) When should this type of testing not be used? Why?
1) Inexpensive and noninvasive but many of the commercial versions (especially rapid office tests) do not perform well (low sensitivity and specificity)
2) Guidelines do not recommend serologic testing for populations with low prevalence of H. pylori (much of the U.S.) due to high number of false positives
Describe biopsy urease tests for H. pylori (endoscopic)
-Biopsy specimen(s) placed into gel with urea > if H. pylori (with urease) is present, urea is broken down releasing ammonia, raising pH and leading to color change (+ test)
-Test results can occur within minutes but may require up to 24 h. More convenient than histologic test.
Describe histologic exam of biopsy specimen for H. pylori
-Antral or duodenal biopsy specimen obtained, special stain for H. pylori added, and tissue viewed under microscopy to look for H. pylori organisms
-Can also give information about associated tissue lesions on the biopsy (inflammation, etc.)
Microbiologic culture for H. pylori:
1) How can this be obtained?
2) How long does it take?
3) Sens. and specificity?
4) Pro to using it?
1) Can be cultured from a mucosal specimen obtained through a gastroscope
2) Takes several weeks (don’t wait for results before beginning treatment)
3) Most specific, but low sensitivity because H. pylori is difficult to isolate with culture
4) Added benefit of being able to determine antibiotic susceptibility to guide treatment
1) What do urea breath test/stool antigen tests and endoscopy-based testing do for H. pylori?
2) What does choice of test depend on?
3) What does not distinguish active and past infection?
1) Identify active infection and can be used to confirm eradication after treatment
2) Need for upper endoscopy
3) Serology
1) What is celiac?
2) What happens with this condition?
3) What develop?
1) Immune disorder triggered by environmental allergen (dietary gluten, which is made of gliadins and glutenins)
2) Presence of gluten-derived peptides (e.g., gliadin) triggers mucosal inflammation of the small intestine
-Damages the lining, affecting the small intestine’s ability to absorb nutrients
3) Antibodies develop
Celiac:
1) When is a diagnostic test ideally performed?
2) In most pts how is Dx established?
3) Generally what Dx tool do you start with?
1) Ideally performed while patient is on gluten-containing diet
2) In most patients, the diagnosis is established by positive celiac serology + positive small bowel biopsy
Sometimes results are discordant, in which case additional testing can help establish diagnosis
3) Generally, will start with serologic testing and then if indicated follow-up with biopsy
What are the classic CD duodenal biopsy findings?
Increased intraepithelial lymphocytes with crypt hyperplasia +/- villous atrophy
1) What is the preferred test for celiac disease in adults?
2) What else can be used?
1) tTg-IgA (an anti-tissue transglutaminase antibody)
2) tTg-IgG (or DGP-IgG)
What are the two groups of autoantibodies regarding celiac?
1) Anti-tissue transglutaminase antibodies (tTg-IgA, tTg-IgG)
2) Anti-endomysial antibody (EMA-IgA)
20
20
20
1) Second leading cause of cancer death in men and women in U.S. is what?
2) Is it easy to screen? Should it be screened?
1) Colorectal cancer (CRC)
2) Easy to screen (Embarrassment/bowel prep are the biggest hurdles)
Much higher survival rate with early treatment
USPSTF recommends screening ages 45*-75 (asymptomatic, average risk)
CRC Screening Tests: List 2 and describe what they detect
1) Stool-based tests, to detect:
-Hemoglobin in stool (bleeding from CRC lesion): e.g., gFOBT, FIT
-DNA alterations suggestive of malignancy
-Examinations that visualize structure of colon
-Radiologic imaging to visualize lesions (e.g., CT colonography)
2) Direct visualization with endoscopy:
a) Flexible Sigmoidoscopy: only visualizes rectosigmoid and descending colon
b) Colonoscopy: exams entire colon; scope allows biopsy and lesion removal at time of test
Describe the recommendations for colorectal cancer screening for average-risk individuals aged ≥ 45 years
1) Stool-based tests:
-Annual fecal occult blood testing (FOBT) using higher sensitivity tests (Hemoccult SENSA) [gFOBT]
-Annual fecal immunochemical test (FIT)
-Fecal DNA test (with FIT every 1–3 years)
2) Endoscopic tests: Colonoscopy every 10 years
Flexible sigmoidoscopy every 5 years
3) Radiologic tests: CT colonography every 5 years